Significant predictors of preference for inhaled versus injectable insulin in patients with type 2 diabetes

被引：0
|
作者：
Hayes, R. P. [1 ]
Stump, T. E. [1 ]
Muchmore, D. B. [1 ]
Schmitkel, J. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0974
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [41] Patient-Reported Outcomes in Adults with Type 2 Diabetes Using Mealtime Inhaled Technosphere Insulin and Basal Insulin Versus Premixed Insulin
    Peyrot, Mark
    Rubin, Richard R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (12) : 1201 - 1206
  • [42] Achieving target HbAIC in studies with inhaled insulin in Type 2 diabetes
    Bergenstal, M
    DIABETOLOGIA, 2004, 47 : A312 - A312
  • [43] Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
    Rosenstock, Julio
    Lorber, Daniel L.
    Gnudi, Luigi
    Howard, Campbell P.
    Bilheimer, David W.
    Chang, P-C
    Petrucci, Richard E.
    Boss, Anders H.
    Richardson, Peter C.
    LANCET, 2010, 375 (9733): : 2244 - 2253
  • [44] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [45] Predictors of hypoglycemia in insulin-treated patients with type 2 diabetes mellitus in Basrah
    Nassar, Dhuha Tarik
    Habib, Omran S.
    Mansour, Abbas Ali
    WORLD JOURNAL OF DIABETES, 2016, 7 (18): : 470 - 480
  • [46] Predictors of Self-Efficacy in Insulin-Treated Patients with Type 2 Diabetes
    Hayes, Risa P.
    Curtis, Bradley H.
    Mao, Xuejing
    Carey, Michelle A.
    Ilag, Liza L.
    DIABETES, 2010, 59 : A524 - A524
  • [47] Predictors of glycemic control after decline of insulin therapy by patients with type 2 diabetes
    Florez, Luisa
    Shubina, Maria
    Turchin, Alexander
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (11)
  • [48] Predictors of achieving glycaemic targets in patients with type 2 diabetes treated with exenatide or insulin
    Brodows, R.
    Milton, D.
    Mao, J.
    Wintle, M.
    Trautmann, M.
    DIABETOLOGIA, 2007, 50 : S352 - S352
  • [49] Patient satisfaction and quality of life in type 1 diabetes: A randomized trial of injectable vs. inhaled insulin
    Testa, MA
    Turner, RR
    Hayes, JF
    Simonson, DC
    DIABETES, 2001, 50 : A45 - A45
  • [50] A comparison of the pharmacodynamic effects of inhaled insulin versus subcutaneous insulin in Type 1 diabetic patients
    Kipnes, M
    Otulana, B
    Clauson, P
    Fischer, J
    Farr, SJ
    Hatorp, V
    Schwartz, S
    DIABETES, 1999, 48 : A95 - A95
12345